Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence

Nat Commun. 2024 Jul 25;15(1):6275. doi: 10.1038/s41467-024-50582-9.

Abstract

Retrospective cohort studies in Cameroon found an association between Onchocerca volvulus microfilarial load in childhood (measured in 1991-1993) and risk of developing epilepsy later in life (measured in 2017). We parameterised and integrated this relationship (across children aged 3-15 years) into the previously published, stochastic transmission model, EPIONCHO-IBM, for Simulium damnosum sensu lato-transmitted onchocerciasis. We simulated 19 years (1998-2017) of annual ivermectin mass drug administration (MDA) reflecting coverage in the study area, and modelled epilepsy prevalence and incidence. Scenario-based simulations of 25 years of (annual and biannual) MDA in hyper- and holoendemic settings, with 65% and 80% therapeutic coverage, were also conducted. EPIONCHO-IBM predicted 7.6% epilepsy prevalence (compared to 8.2% in the Cameroon study) and incidence of 317 cases/100,000 person-years (compared to 350). In hyperendemic areas, 25 years of biannual MDA (80% coverage) eliminated onchocerciasis-associated epilepsy (OAE) and protected untreated under-fives from its development. Strengthening onchocerciasis programmes, implementing alternative strategies, and evaluating treatment for under-fives and school-age children are crucial to prevent OAE in highly-endemic settings.

MeSH terms

  • Adolescent
  • Animals
  • Cameroon / epidemiology
  • Child
  • Child, Preschool
  • Epilepsy* / drug therapy
  • Epilepsy* / epidemiology
  • Epilepsy* / parasitology
  • Female
  • Humans
  • Incidence
  • Ivermectin* / therapeutic use
  • Male
  • Mass Drug Administration
  • Onchocerca volvulus* / drug effects
  • Onchocerciasis* / complications
  • Onchocerciasis* / drug therapy
  • Onchocerciasis* / epidemiology
  • Prevalence
  • Retrospective Studies
  • Simuliidae / parasitology

Substances

  • Ivermectin